Fidelity Investments’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36.1M Buy
38,137,535
+3,594,338
+10% +$3.4M ﹤0.01% 1501
2025
Q1
$15.9M Sell
34,543,197
-17,427,258
-34% -$8.03M ﹤0.01% 1752
2024
Q4
$38.4M Buy
51,970,455
+2,103,413
+4% +$1.55M ﹤0.01% 1490
2024
Q3
$78.3M Buy
49,867,042
+11,179,919
+29% +$17.6M ﹤0.01% 1199
2024
Q2
$65M Buy
38,687,123
+24,793,061
+178% +$41.7M ﹤0.01% 1207
2024
Q1
$33.3M Buy
13,894,062
+11,617,594
+510% +$27.9M ﹤0.01% 1476
2023
Q4
$3.48M Sell
2,276,468
-5,286,608
-70% -$8.09M ﹤0.01% 2166
2023
Q3
$8.24M Sell
7,563,076
-947,992
-11% -$1.03M ﹤0.01% 1885
2023
Q2
$19.5M Buy
8,511,068
+3,270,821
+62% +$7.49M ﹤0.01% 1648
2023
Q1
$12.7M Sell
5,240,247
-11,438
-0.2% -$27.8K ﹤0.01% 1781
2022
Q4
$10M Sell
5,251,685
-31,314
-0.6% -$59.8K ﹤0.01% 1889
2022
Q3
$12.7M Sell
5,282,999
-7,615
-0.1% -$18.3K ﹤0.01% 1801
2022
Q2
$9.84M Buy
5,290,614
+65
+0% +$121 ﹤0.01% 1973
2022
Q1
$11.1M Sell
5,290,549
-377,589
-7% -$789K ﹤0.01% 2080
2021
Q4
$22.3M Sell
5,668,138
-793,218
-12% -$3.13M ﹤0.01% 1768
2021
Q3
$31.1M Sell
6,461,356
-975,157
-13% -$4.69M ﹤0.01% 1632
2021
Q2
$34.1M Sell
7,436,513
-1,666,325
-18% -$7.65M ﹤0.01% 1600
2021
Q1
$53.4M Buy
9,102,838
+804,738
+10% +$4.72M ﹤0.01% 1370
2020
Q4
$28.4M Sell
8,298,100
-987,874
-11% -$3.38M ﹤0.01% 1554
2020
Q3
$13.4M Sell
9,285,974
-1,733,300
-16% -$2.5M ﹤0.01% 1731
2020
Q2
$22M Sell
11,019,274
-1,302,320
-11% -$2.6M ﹤0.01% 1509
2020
Q1
$24M Sell
12,321,594
-237,900
-2% -$464K ﹤0.01% 1331
2019
Q4
$52.1M Sell
12,559,494
-525,400
-4% -$2.18M 0.01% 1192
2019
Q3
$39.4M Sell
13,084,894
-403,200
-3% -$1.21M ﹤0.01% 1288
2019
Q2
$84.8M Sell
13,488,094
-890,820
-6% -$5.6M 0.01% 985
2019
Q1
$79.9M Sell
14,378,914
-360,700
-2% -$2.01M 0.01% 996
2018
Q4
$97.9M Sell
14,739,614
-764,366
-5% -$5.08M 0.01% 857
2018
Q3
$165M Sell
15,503,980
-370,800
-2% -$3.96M 0.02% 735
2018
Q2
$190M Buy
15,874,780
+36,006
+0.2% +$432K 0.02% 687
2018
Q1
$136M Buy
15,838,774
+605
+0% +$5.19K 0.02% 854
2017
Q4
$156M Buy
15,838,169
+953
+0% +$9.42K 0.02% 785
2017
Q3
$195M Buy
15,837,216
+51,936
+0.3% +$638K 0.02% 695
2017
Q2
$260M Buy
15,785,280
+137,421
+0.9% +$2.26M 0.03% 575
2017
Q1
$224M Buy
15,647,859
+42,408
+0.3% +$608K 0.03% 644
2016
Q4
$216M Buy
15,605,451
+25,595
+0.2% +$354K 0.03% 634
2016
Q3
$282M Buy
15,579,856
+6,644
+0% +$120K 0.04% 518
2016
Q2
$223M Buy
15,573,212
+7,764
+0% +$111K 0.03% 617
2016
Q1
$186M Buy
15,565,448
+22,035
+0.1% +$263K 0.03% 690
2015
Q4
$207M Buy
15,543,413
+1,452
+0% +$19.3K 0.03% 638
2015
Q3
$167M Buy
15,541,961
+626,869
+4% +$6.73M 0.02% 719
2015
Q2
$120M Sell
14,915,092
-381,362
-2% -$3.07M 0.02% 950
2015
Q1
$101M Hold
15,296,454
0.01% 1023
2014
Q4
$97.4M Buy
15,296,454
+4,264,636
+39% +$27.2M 0.01% 1013
2014
Q3
$109M Sell
11,031,818
-2,657
-0% -$26.2K 0.01% 933
2014
Q2
$124M Buy
11,034,475
+24,682
+0.2% +$278K 0.02% 884
2014
Q1
$133M Buy
11,009,793
+335,016
+3% +$4.06M 0.02% 822
2013
Q4
$135M Sell
10,674,777
-327,796
-3% -$4.13M 0.02% 821
2013
Q3
$183M Buy
11,002,573
+9,174
+0.1% +$152K 0.03% 656
2013
Q2
$167M Buy
+10,993,399
New +$167M 0.03% 660